DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[Docket No. 3-84]
49 FR 5980
February 16, 1984
Proposed Foreign-Trade Zone -- Albuquerque, New Mexico, With Subzone for
Summa Medical Corp.; Application and Public Hearing
TEXT: An application has been submitted to the Foreign-Trade Zones Board
(the Board) by the City of Albuquerque, New Mexico, requesting authority
to establish a general-purpose foreign-trade zone and a special-purpose
subzone for Summa Medical Corporation in Albuquerque, within the
Albuquerque Customs port of entry. The application was submitted pursuant
to the provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C.
81a-81u), and the regulations of the Board (15 CFR Part 400). It was
formally filed on January 30, 1984. The applicant is authorized to make
this proposal under Section 3-18-29, New Mexico Statutes Annnotated, 1978.
The proposed general-purpose zone will be located at 1414 -- 12th
Street, NW., Albuquerque. Covering 2.5 acres, the site has an existing
50,000 square foot warehouse building available for zone activity. The
City has selected FTZ Operators of New Mexico to administer the zone
project. Albuquerque Assembly and Distribution Freeport Warehouse
Corporation will operate the zone warehousing services.
The application contains evidence of the need for general-purpose zone
services in the Albuquerque area. Several firms have expressed an interest
in using zone procedures to warehouse/distribute products, such as
electronic articles, instruments, pesticides, transportation components,
apparel and food products. No requests for manufacturing in the
general-purpose zone are being made at this time; such requests would be
made to the Board on a case-by-case basis.
The proposed subzone will be located at Summa Medical Corporation's
research and production facility, 4272 Balloon Park Road, Albuquerque. It
occupies 2,000 square feet in an industrial park building. The special
"clean room" facility is used to develop and manufacture oncologic
pharmaceuticals. Summa purchases special bio-chemical raw materials from
foreign sources. The company will begin exporting the products on a
commercial basis upon FDA approval. Future plans call for substantial sales
to the domestic market after FDA certifies the drugs.
Zone procedures will exempt the company from duty payments on the
foreign items it uses for its exports. In the future, secondary savings
will result from deferral of duty and possible duty rate adjustment on
products destined for the domestic market. These savings will help
encourage Summa to continue production operations in the U.S. and create
the environment for the possible increase in operations, adding up to 35
persons to the current workforce of 15.
In accordance with the Board's regulations, an examiners committee has
been appointed to investigate the application and report to the Board. The
committee consists of: John J. Da Ponte, Jr. (Chairman), Director,
Foreign-Trade Zones Staff, U.S. Department of Commerce, Washington, D.C.
20230; Donald Gough, Deputy Assistant Regional Commissioner, U.S. Customs
Service, Southwest Region, 5850 San Felipe Street, Houston, TX 77057; and
Lt. Colonel Julian E. Plyant, Jr., District Engineer, U.S. Army Engineer
District Albuquerque, P.O. Box 1580, Albuquerque, NM 87103.
As part of its investigation, the examiners committee will hold a
public hearing on March 14, 1984, beginning at 9:00 a.m., in the Otto
Miller Room of the Albuquerque Convention Center, 401 Second Street.
Interested parties are invited to present their views at the hearing.
Persons wishing to testify should notify the Board's Executive Secretary
in writing at the address below or by phone (202/377-2862) by March 7.
Instead of an oral presentation, written statements may be submitted in
accordance with the Board's regulations to the examiners committee, care
of the Executive Secretary, at any time from the date of this notice
through April 13, 1984.
A copy of the application and accompanying exhibits will be available
during this time for public inspection at each of the following locations:
U.S. Dept. of Commerce District Office, Suite 1015,
505 Marquette Avenue, NW.,
Albuquerque, NM 87102
Office of the Executive Secretary,
Foreign-Trade Zones Board,
U.S. Department of Commerce, Room 1872,
14th and Pennsylvania, NW.,
Washington, D.C. 20230
Dated: February 10, 1984.
John J. Da Ponte, Jr.,
[FR Doc. 84-4239 Filed 2-15-84; 8:45 am]
BILLING CODE 3510-DS-M